Physician profile
Robert Bernard Gaston
NPI 1003897380
$14,570.23
in general payments reported to CMS, 2019-2025
62 companies · $2,589 in 2025
The $2,589 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,187 · 2020: $1,761 · 2021: $2,296 · 2022: $2,147 · 2023: $2,146 · 2024: $2,444 · 2025: $2,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,178.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,829.49 | 2021-2025 | |
| Novo Nordisk INC | $1,620.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,403.61 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,231.97 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,115.49 | 2019-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $950.42 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $522.28 | 2019-2023 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $422.17 | 2019-2025 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $352.98 | 2021-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $351.88 | 2021-2025 | |
| Exact Sciences Corporation | $323.79 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $279.69 | 2020-2025 | Jardiance, Kisunla, Mounjaro |
| Allergan, INC. | $270.82 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $251.70 | 2019-2023 | Austedo |
| Biohaven Pharmaceuticals, INC. | $233.55 | 2020-2021 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gaston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.